Angiodynamics reports fiscal 2020 q4 and full-year results

Angiodynamics reports fiscal 2020 fourth quarter and full-year financial results.q4 earnings per share $0.04 excluding items.q4 loss per share $4.10 from continuing operations.q4 sales $58.3 million versus refinitiv ibes estimate of $68.2 million.q4 earnings per share estimate $-0.05 -- refinitiv ibes data.angiodynamics - q4 vascular access net sales were $23.7 million, a decrease of 4.6% from $24.9 million a year ago.management will not be providing financial guidance for fiscal 2021 at this point in time.remains focused on cash preservation amid current environment.angiodynamics - will not be providing financial guidance for fiscal 2021 at this point in time.
ANGO Ratings Summary
ANGO Quant Ranking